The rise in the prevalence of lifestyle and infectious diseases and the increasing inclination towards home healthcare across the globe, are major factors driving the growth of global Point-of-care diagnostics market. Whereas, along with the growing government support to increase the adoption of POC devices; private investments and venture funding towards the development of new products is further fueling the growth of this market. These factors propelling the Global point-of-care diagnostics market to grow at the CAGR of 10.1% from 2017 to 2022, which is expected to take the market that was valued at USD 23 billion in 2016 to USD 41 billion by 2022.

In addition to driving factors, emerging markets including China, India, and Brazil are offering high growth opportunities for companies which are engaged in the development and distribution of point-of-care diagnostic devices. This is mainly because of the growing initiatives by market players, increasing patient population base, and the rising number of partnerships and joint ventures among POC providers.

This report presents most of such influencing factors affecting market growth, in detail. Along with that, this report also talks about industry trends, and pricing analysis.

This research study involved the extensive usage of both primary and secondary data sources to build this market to such drill down segmentation level on the basis of product prescription mode, and geographic region.

Global Point-of-care Diagnostics Market, by Product

Glucose Monitoring Kits
Cardiometabolic Monitoring Kits
- Cardiac Markers
- Blood Gas/Electrolytes Testing Kits
- HbA1c Testing Kits
- Lipids Testing
Infectious Diseases Testing Kits
- Influenza Testing Kits
- HIV Testing Kits
- Hepatitis C Testing Kits
- Sexually-transmitted Diseases (STDs) Testing Kits
- Tropical Diseases Testing Kits
- Healthcare-associated Infections (HAIs)
- Respiratory Infections Testing Kits
- Others
Coagulation Monitoring Kits
- Prothrombin Time (PT/INR) Testing Kits
- Activated Clotting Time (ACT/APTT) Testing Kits
Pregnancy and Fertility Testing Kits
- Pregnancy Testing Kits
- Fertility Testing Kits
Tumor/Cancer Markers
Urinalysis Testing Kits
Cholesterol Test Strips
Hematology Testing Kits
Drugs of Abuse Testing Kits
Fecal Occult Testing Kits
Others

Global Point-of-care Diagnostics Market, by Prescription Mode

Prescription-based Testing Kits
Over-the-counter (OTC) Testing Kits

Global Point-of-care Diagnostics Market, by End User

Professional Diagnostic Centers
- Hospitals/Critical Care Centers
- Outpatient Healthcare Settings
- Ambulatory Care Settings
Research Laboratories
Home Care
Other End Users

Global Point-of-care Diagnostics Market, by Region

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- Rest of Asia-Pacific
Rest of the World

Competitive Intelligence is one more important section of this report which includes market share analysis and company profile of 10 key players operating in this market. The key players in this market are Abbott Laboratories, Inc. (U.S.),Roche Diagnostics Limited (Switzerland), Siemens AG (Germany), Beckman Coulter, Inc. (U.S.),Becton, Dickinson and Company (U.S.), Johnson & Johnson (U.S.), Alere Inc. (U.S.), Instrumentation Laboratory (U.S.), PTS Diagnostics (U.S.), and Nova Biomedical (U.S.).

Company profile section includes company introduction, product and/or services offered by company, its financials and related recent developments for last 3 years. (The financials and recent developments that is available in public domain will be included).

Available customizations:

With the given market data, we also offers customizations as per the client’s specific needs. The following customization options are available for the report:

Product Analysis

Product matrix, which gives a detailed comparison of the product portfolios of the top five companies in the point-of-care diagnostics market

Company Information

Detailed analysis and profiling of additional market players (up to five)

Table of Contents

1. Introduction

1.1. Objectives of the Study

1.2. Market Definition

1.3. Markets Scope

1.3.1. Markets Covered

1.3.2. Years Considered for the Study

1.4. Currency Conversion Rates

1.5. Limitations

2. Research Methodology

2.1. Research Methodology Steps

2.2. Research Design

2.3. Market Breakdown and Data Triangulation

2.4. Research Assumptions and Limitations

2.4.1. Assumptions for the Study

2.4.2. Limitations

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Market Dynamics – DROC

4.2.1. Market Driver

4.2.2. Market Restraint

4.2.3. Market Opportunities

4.2.4. Market Challenges

5. Industry Insights

5.1. Introduction

5.2. Industry Trends

5.3. Pricing Analysis

5.4. Porter’s Five Forces Analysis

6. Point-of-Care Diagnostics Market, By Product

6.1. Introduction

6.2. Glucose Monitoring Kits

6.3. Cardiometabolic Monitoring Kits

6.3.1. Cardiac Markers

6.3.2. Blood Gas/Electrolytes Testing Kits

6.3.3. HBA1C Testing Kits

6.3.4. LIPID Testing Kits

6.4. Infectious Disease Testing Kits

6.4.1. Influenza Testing Kits

6.4.2. HIV Testing Kits

6.4.3. Hepatitis C Testing Kits

6.4.4. Sexually Transmitted Diseases (STDs) Testing Kits

6.4.5. Tropical Diseases Testing Kits

6.4.6. Healthcare-Associated Infection Testing Kits

6.4.7. Respiratory Infections Testing Kits

6.4.8. Other Infectious Disease Testing Kits

6.5. Coagulation Monitoring Kits

6.5.1. PT/INR Testing Kits

6.5.2. Activated Clotting Time (ACT/APTT) Testing Kits

6.6. Pregnancy and Fertility Testing Kits

6.6.1. Pregnancy Testing Kits

6.6.2. Fertility Testing Kits

6.7. Tumor/Cancer Markers

6.8. Urinalysis Testing Kits

6.9. Cholesterol Test Strips

6.10. Hematology Testing Kits

6.11. Drugs-Of-Abuse Testing Kits

6.12. Fecal Occult Testing Kits

6.13. Other POC Testing Kits

7. Point-of-Care Diagnostics Market, By Prescription Mode

7.1. Introduction

7.2. Prescription-Based Testing Kits

7.3. OTC Testing Kits Market

8. Point-of-Care Diagnostics Market, By End User

8.1. Introduction

8.2. Professional Diagnostic Centers

8.2.1. Hospitals/Critical Care Settings

8.2.2. Outpatient Healthcare Settings

8.2.3. Ambulatory Care Settings

8.3. Research Laboratories

8.4. Home Care

8.5. Others

9. Point-of-Care Diagnostics Market, By Region

9.1. Introduction

9.2. North America

9.2.1. U.S.

9.2.2. Canada

9.3. Europe

9.3.1. Germany

9.3.2. U.K.

9.3.3. France

9.3.4. RoE

9.4. Asia-Pacific

9.4.1. China

9.4.2. Japan

9.4.3. India

9.4.4. RoAPAC

9.5. Rest of the World

10. Competitive Intelligence

10.1. Introduction

10.2. Market Share Analysis

10.3. Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.)

10.4. Abbott Laboratories, Inc.

10.5. Siemens AG

10.6. Alere Inc.

10.7. Johnson & Johnson

10.8. Instrumentation Laboratory (A Werfen Company)

10.9. Nova Biomedical

10.10. Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)

10.11. Becton, Dickinson and Company

10.12. PTs Diagnostics

*Company profiled in this section will include introduction to company, its products and services offerings. This section will also include company financials and company’s recent developments (related to market), if available in public domain.

11. Appendix

11.1. Available Customizations

11.2. Related Reports

List of Tables

Table 1 Point-Of- Care Diagnostics Market Size, By Product, 2015–2022 (USD Million)
Table 2 Point-of- Care Diagnostics Market Size, By Region, 2015–2022 (USD Million)
Table 3 Glucose Monitoring Kits Market Size, By Region, 2015–2022 (USD Million)
Table 4 Cardiometabolic Monitoring Kits Market Size, By Type, 2015–2022 (USD Million)
Table 5 Cardiometabolic Monitoring Kits Market Size, By Region, 2015–2022 (USD Million)
Table 6 Cardiac Markers Market Size, By Region, 2015–2022 (USD Million)
Table 7 Blood Gas/Electrolytes Market Size, By Region, 2015–2022 (USD Million)
Table 8 HBA1C Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 9 LIPID Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 10 Infectious Disease Testing Kits Market Size, By Type, 2015–2022 (USD Million)
Table 11 Infectious Disease Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 12 Influenza Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 13 HIV Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 14 Hepatitis C Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 15 STD Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 16 Tropical Diseases Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 17 Healthcare-Associated Infection Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 18 Respiratory Infections Testing Kits Market Size, By Region, 2014–-2021 (USD Million)
Table 19 Other Infectious Disease Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 20 Coagulation Monitoring Kits Market Size, By Type, 2015–2022 (USD Million)
Table 21 Coagulation Monitoring Kits Market Size, By Region, 2015–2022 (USD Million)
Table 22 PT/INR Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 23 ACT/APTT Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 24 Pregnancy and Fertility Testing Kits Market Size, By Type, 2015–2022 (USD Million)
Table 25 Pregnancy and Fertility Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 26 Pregnancy Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 27 Fertility Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 28 Tumor/Cancer Markers Market Size, By Region, 2015–2022 (USD Million)
Table 29 Urinalysis Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 30 Cholesterol Test Strips Market Size, By Region, 2015–2022 (USD Million)
Table 31 Hematology Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 32 Drugs-Of- Abuse Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 33 Fecal Occult Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 34 Other POC Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 35 Point-of- Care Diagnostics Market Size, By Prescription Mode, 2015–2022 (USD Million)
Table 36 Prescription-Based Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 37 OTC Testing Kits Market Size, By Region, 2015–2022 (USD Million)
Table 38 Market Size, By End User, 2015–2022 (USD Million)
Table 39 Professional Diagnostic Centers Market Size, By Type, 2015–2022 (USD Million)
Table 40 Professional Diagnostic Centers Market Size, By Region, 2015–2022 (USD Million)
Table 41 Research Laboratories Market Size, By Region, 2015–2022 (USD Million)
Table 42 Home Care Point-of- Care Diagnostics Market Size, By Region, 2015–2022 (USD Million)
Table 43 Other End Users Point-of- Care Diagnostics Market Size, By Region, 2015–2022 (USD Million)
Table 44 Point-of- Care Diagnostics Market Size, By Region, 2015–2022 (USD Million)
Table 45 North America: Point-of- Care Diagnostics Market Size, By Country, 2015–2022 (USD Million)
Table 46 North America Market Size, By Product, 2015–2022 (USD Million)
Table 47 North America Market Size, By Prescription Mode, 2015–2022 (USD Million)
Table 48 North America Market Size, By End User, 2015–2022 (USD Million)
Table 49 U.S. Market Size, By Product, 2015–2022 (USD Million)
Table 50 U.S. Size, Market By Prescription Mode, 2015–2022 (USD Million)
Table 51 U.S. Market Size, By End User, 2015–2022 (USD Million)
Table 52 Canada: Market Size, By Product, 2015–2022 (USD Million)
Table 53 Canada: Market Size, By Prescription Mode, 2015–2022 (USD Million)
Table 54 Canada: Market Size, By End User, 2015–2022 (USD Million)
Table 55 Europe: Market Size, By Country, 2015–2022 (USD Million)
Table 56 Europe: Market Size, By Product, 2015–2022 (USD Million)
Table 57 Europe: Market Size, By Prescription Mode, 2015–2022 (USD Million)
Table 58 Europe: Market Size, By End User, 2015–2022 (USD Million)
Table 59 Germany: Point-of- Care Diagnostics Market Size, By Product, 2015–2022 (USD Million)
Table 60 Germany: Market Size, By Prescription Mode, 2015–2022 (USD Million)
Table 61 Germany: Market Size, By End User, 2015–2022 (USD Million)
Table 62 France: Point-of- Care Diagnostics Market Size, By Product, 2015–2022 (USD Million)
Table 63 France: Market Size, By Prescription Mode, 2015–2022 (USD Million)
Table 64 France: Market Size, By End User, 2015–2022 (USD Million)
Table 65 U.K.: Market Size, By Product, 2015–2022 (USD Million)
Table 66 U.K.: Market Size, By Prescription Mode, 2015–2022 (USD Million)
Table 67 U.K.: Market Size, By End User, 2015–2022 (USD Million)
Table 68 RoE: Market Size, By Product, 2015–2022 (USD Million)
Table 69 RoE: Market Size, By Prescription Mode, 2015–2022 (USD Million)
Table 70 RoE: Point-of- Care Diagnostics Market Size, By End User, 2015–2022 (USD Million)
Table 71 APAC: Market Size, By Country, 2015–2022 (USD Million)
Table 72 APAC: Market Size, By Product, 2015–2022 (USD Million)
Table 73 APAC: Market Size, By Prescription Mode, 2015–2022 (USD Million)
Table 74 APAC: Market Size, By End User, 2015–2022 (USD Million)
Table 75 Japan: Market Size, By Product, 2015–2022 (USD Million)
Table 76 Japan: Market Size, By Prescription Mode, 2015–2022 (USD Million)
Table 77 Japan: Market Size, By End User, 2015–2022 (USD Million)
Table 78 China: Market Size, By Product, 2015–2022 (USD Million)
Table 79 China: Market Size, By Prescription Mode, 2015–2022 (USD Million)
Table 80 China: Market Size, By End User, 2015–2022 (USD Million)
Table 81 India: Market Size, By Product, 2015–2022 (USD Million)
Table 82 India: Market Size, By Prescription Mode, 2015–2022 (USD Million)
Table 83 India: Point-of- Care Diagnostics Market Size, By End User, 2015–2022 (USD Million)
Table 84 RoAPAC: Market Size, By Product, 2015–2022 (USD Million)
Table 85 RoAPAC: Market Size, By Prescription Mode, 2015–2022 (USD Million)
Table 86 RoAPAC: Market Size, By End User, 2015–2022 (USD Million)
Table 87 RoW: Market Size, By Product, 2015–2022 (USD Million)
Table 88 RoW: Market Size, By Prescription Mode, 2015–2022 (USD Million)
Table 89 RoW: Market Size, By End User, 2015–2022 (USD Million)

List of Figures

Figure 1 Global Point-of- Care (POC) Market
Figure 2 Bottom-Up Approach
Figure 3 Top-Down Approach
Figure 3 Data Triangulation
Figure 4 Global Point-of- Care Diagnostics Market, By Product, 2016 & 2022 (USD Million)
Figure 5 Global Rapid Diagnostic Market, By Prescription Mode, 2016 & 2022 (USD Million)
Figure 6 Global Market, By Platform, 2016 & 2022
Figure 7 Global Rapid Diagnostic Market, By End User, 2016 & 2022
Figure 8 Global Market, By Region, 2016 (USD Million)
Figure 10 Lateral Flow Assays Segment Will Continue to Dominate the Market in 2022
Figure 11 Professional Diagnostic Centers Segment to Dominate the Global Point-of- Care (POC) Diagnostics End-User Market in 2017
Figure 12 Glucose Monitoring Segment to Dominate the Point-of- Care (POC) Diagnostics Products Market During the Forecast Period
Figure 13 Prescription Based Testing Products to Dominate the Point-of- Care (POC) Diagnostics Market During the Forecast Period
Figure 14 North America to Register the Highest CAGR During the Forecast Period
Figure 15 Point-of- Care (POC) Diagnostics Market - DROC
Figure 16 Approx Number of Diabetic Patients, By Region
Figure 17 The Infectious Disease Testing Products Segment is Projected to Grow at the Highest CAGR, 2022
Figure 18 Molecular Diagnostics Segment to Witness Highest Growth, 2022
Figure 19 OTC Testing Segment to Witness Higher Growth, 2022
Figure 20 Home Care to Witness Highest Growth, 2022
Figure 21 Rapid Diagnostic Market, Growth Forecast, By Region (2016–2022)
Figure 22 North America Rapid Diagnostic Market Depiction
Figure 23 Europe Rapid Diagnostic Market Depiction
Figure 24 Asia-Pacific Rapid Diagnostic Market Depiction
Figure 25 Rest of the World Rapid Diagnostic Market Depiction
Figure 26 Point-of- Care Diagnostics Market Share, By Key Players, 2016

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.

Enquire Before Buy

Ask for Discount

We provide customized solutions that perfectly suit and help resolve your business demands. Let our Research Consultants reach out to you to address your queries and needs.

sales@quintagoinsights.com

Key Benefits

Point-of-Care Diagnostics Market by Products (Glucose, Cardiometabolic Monitoring, & Infectious Disease Testing Kits, Cardiac & Tumor Markers), End Users (Home, Hospitals, Ambulatory Care), Over-the-Counter & Prescription Based - Global Forecast to 2022

Menu 3

Custom Research Solution

Customer Fulfilment

360-Degree Approach